Halozyme Therapeutics Total Assets 2010-2024 | HALO

Halozyme Therapeutics total assets for the quarter ending June 30, 2024 were $1.969B, a 8.78% increase year-over-year.

  • Halozyme Therapeutics total assets for 2023 were $1.733B, a 5.88% decline from 2022.
  • Halozyme Therapeutics total assets for 2022 were $1.842B, a 66.74% increase from 2021.
  • Halozyme Therapeutics total assets for 2021 were $1.104B, a 90.44% increase from 2020.

Halozyme Therapeutics Total Assets 2010-2024 | HALO

  • Halozyme Therapeutics total assets for 2023 were $1.733B, a 5.88% decline from 2022.
  • Halozyme Therapeutics total assets for 2022 were $1.842B, a 66.74% increase from 2021.
  • Halozyme Therapeutics total assets for 2021 were $1.104B, a 90.44% increase from 2020.